Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1994 1
1996 2
1997 3
1998 1
1999 1
2000 1
2001 2
2002 2
2003 1
2004 3
2005 4
2006 2
2007 4
2008 9
2009 5
2010 2
2011 3
2012 5
2013 5
2014 8
2015 6
2016 8
2017 10
2018 7
2019 5
2020 7
2021 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Antirheumatic, 2Fadministration, 5BMAJR
Page 1
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Chai-Adisaksopha C, Nevitt SJ, Simpson ML, Janbain M, Konkle BA. Chai-Adisaksopha C, et al. Cochrane Database Syst Rev. 2017 Sep 25;9(9):CD011441. doi: 10.1002/14651858.CD011441.pub2. Cochrane Database Syst Rev. 2017. PMID: 28944952 Free PMC article. Review.
AUTHORS' CONCLUSIONS: The evidence suggests that prophylaxis with bypassing agents may be effective in reducing bleeding in males with hemophilia with inhibitors. However, there is a lack of evidence for the superiority of one agent over the other or for the optimum …
AUTHORS' CONCLUSIONS: The evidence suggests that prophylaxis with bypassing agents may be effective in reducing bleeding in males wit …
The role of calcium and non calcium-based phosphate binders in chronic kidney disease.
Elder GJ, Center J. Elder GJ, et al. Nephrology (Carlton). 2017 Mar;22 Suppl 2:42-46. doi: 10.1111/nep.13031. Nephrology (Carlton). 2017. PMID: 28429551 Review.
In general, it seems prudent to avoid prescribing calcium-based drugs to patients who are pre-dialysis, and to use non-CBBs preferentially in CKD stage 5D. Current draft Kidney Disease Improving Global Outcomes guidelines suggest that CBB dosage be minimized in CKD …
In general, it seems prudent to avoid prescribing calcium-based drugs to patients who are pre-dialysis, and to use non-CBBs preferentially i …
Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double-blind, randomized controlled non-inferiority trial.
Kim HJ, Kim JH, Park YS, Suk KS, Lee JH, Park MS, Moon SH. Kim HJ, et al. Spine J. 2016 Jun;16(6):756-63. doi: 10.1016/j.spinee.2016.02.049. Epub 2016 Mar 29. Spine J. 2016. PMID: 27045252 Clinical Trial.
The overall changes of the baseline-adjusted ODI scores, VAS scores for leg pain, the EQ-5D, and ICD during the follow-up assessments over an 8-week period (secondary end point) were not different among the three groups. The baseline-adjusted ODI scores and VAS scores for …
The overall changes of the baseline-adjusted ODI scores, VAS scores for leg pain, the EQ-5D, and ICD during the follow-up assessments …
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
Effects of micro-aeration on microbial niches and antimicrobial resistances in blackwater anaerobic digesters.
Guo B, Yu N, Weissbrodt DG, Liu Y. Guo B, et al. Water Res. 2021 May 15;196:117035. doi: 10.1016/j.watres.2021.117035. Epub 2021 Mar 10. Water Res. 2021. PMID: 33751974
Microbial communities were significantly different under different oxygen dosages (p<0.05), with segregation of microbial ecological niches in low and high oxygen dosage communities. ...Low-oxygen-dosage communities contained a higher prevalence of mobile …
Microbial communities were significantly different under different oxygen dosages (p<0.05), with segregation of microbial ecologic …
[Mineral and bone disorder in chronic kidney disease : Critical appraisal of pharmacotherapy].
Brunkhorst R. Brunkhorst R. Internist (Berl). 2014 Mar;55(3):334-9. doi: 10.1007/s00108-014-3447-4. Internist (Berl). 2014. PMID: 24522558 Review. German.
Low vitamin D concentrations in CKD stages 3-5 should be treated under consideration of serum calcium and parathyroid hormone (PTH) with calcidiol (25-cholecalciferol) and in dialysis patients (CKD 5D) with calcitriol (1,25 dihydroxycholecalciferol, activated vitamin D). . …
Low vitamin D concentrations in CKD stages 3-5 should be treated under consideration of serum calcium and parathyroid hormone (PTH) with cal …
Effect of numbers of sperm and timing of a single, post-cervical insemination on the fertility of weaned sows treated with OvuGel®.
Knox RV, Esparza-Harris KC, Johnston ME, Webel SK. Knox RV, et al. Theriogenology. 2017 Apr 1;92:197-203. doi: 10.1016/j.theriogenology.2017.01.033. Epub 2017 Jan 20. Theriogenology. 2017. PMID: 28237336 Clinical Trial.

Farrowing rate was greater (P < 0.0001) with use of 2.5 than 1.5 billion sperm and insemination at 22 and 26 h compared to 30 h after OvuGel() (P 0.10). Farrowing rate was also affected by parity, estrus expression, ovulation and ovarian abnormalities (P < 0.05). ...

Farrowing rate was greater (P < 0.0001) with use of 2.5 than 1.5 billion sperm and insemination at 22 and 26 h compared to 30 h af

US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
Huang IC, Willke RJ, Atkinson MJ, Lenderking WR, Frangakis C, Wu AW. Huang IC, et al. Qual Life Res. 2007 Aug;16(6):1065-72. doi: 10.1007/s11136-007-9206-4. Epub 2007 Apr 6. Qual Life Res. 2007. PMID: 17415683 Clinical Trial.
The correlation coefficient for EQ-5D utilities using the US and UK weights was 0.98. The correlations of EQ-5D index scores with the MOS-HIV scores were moderate and similar using the US and UK weights. ...The changes in EQ-5D index scores from baseline to w …
The correlation coefficient for EQ-5D utilities using the US and UK weights was 0.98. The correlations of EQ-5D index scores w …
De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease.
Warady BA, Barcia J, Benador N, Jankauskiene A, Olson K, Podracka L, Shavkin A, Srivaths P, Wong CJ, Petersen J. Warady BA, et al. Pediatr Nephrol. 2018 Jan;33(1):125-137. doi: 10.1007/s00467-017-3758-5. Epub 2017 Aug 17. Pediatr Nephrol. 2018. PMID: 28815341 Clinical Trial.
BACKGROUND: Darbepoetin alfa is a commonly prescribed erythropoiesis-stimulating agent (ESA) for correcting anemia in pediatric chronic kidney disease (CKD) patients. ...The median time to achieve hemoglobin 10 g/dl was slightly longer for subjects <12 years (QW and Q2W …
BACKGROUND: Darbepoetin alfa is a commonly prescribed erythropoiesis-stimulating agent (ESA) for correcting anemia in pediatric chron …
Moderately Fermentable Potato Fiber Attenuates Signs and Inflammation Associated with Experimental Colitis in Mice.
Panasevich MR, Allen JM, Wallig MA, Woods JA, Dilger RN. Panasevich MR, et al. J Nutr. 2015 Dec;145(12):2781-8. doi: 10.3945/jn.115.218578. Epub 2015 Oct 21. J Nutr. 2015. PMID: 26491118 Free article.
METHODS: Male C57Bl/6J mice were fed diets containing either 8% cellulose or 14.5% PF for a 22-d feeding study. Starting on study day 14, mice were provided either distilled water (control) or 2% (wt:vol) DSS in drinking water for 5 d (cellulose+control, n = 17; PF+control …
METHODS: Male C57Bl/6J mice were fed diets containing either 8% cellulose or 14.5% PF for a 22-d feeding study. Starting on study day …
101 results